These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


517 related items for PubMed ID: 22494851

  • 61. Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience.
    Yeshurun M, Gafter-Gvili A, Thaler M, Keller N, Nagler A, Shimoni A.
    Infection; 2010 Jun; 38(3):211-5. PubMed ID: 20425134
    [Abstract] [Full Text] [Related]

  • 62. Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of Gram-negative pathogens.
    Marcos M, Soriano A, Iñurrieta A, Martínez JA, Romero A, Cobos N, Hernández C, Almela M, Marco F, Mensa J.
    J Antimicrob Chemother; 2011 Sep; 66(9):2119-25. PubMed ID: 21665905
    [Abstract] [Full Text] [Related]

  • 63. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
    Gales AC, Jones RN, Forward KR, Liñares J, Sader HS, Verhoef J.
    Clin Infect Dis; 2001 May 15; 32 Suppl 2():S104-13. PubMed ID: 11320451
    [Abstract] [Full Text] [Related]

  • 64. An epidemiological analysis of Stenotrophomonas maltophilia strains in a university hospital.
    Caylan R, Kaklikkaya N, Aydin K, Aydin F, Yilmaz G, Ozgumus B, Koksal I.
    Jpn J Infect Dis; 2004 Apr 15; 57(2):37-40. PubMed ID: 15118205
    [Abstract] [Full Text] [Related]

  • 65. Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis.
    Kim SH, Cha MK, Kang CI, Ko JH, Huh K, Cho SY, Chung DR, Peck KR.
    Eur J Clin Microbiol Infect Dis; 2019 Feb 15; 38(2):285-295. PubMed ID: 30421302
    [Abstract] [Full Text] [Related]

  • 66. Evaluation of treatment outcomes for Stenotrophomonas maltophilia bacteraemia.
    Lakatos B, Jakopp B, Widmer A, Frei R, Pargger H, Elzi L, Battegay M.
    Infection; 2014 Jun 15; 42(3):553-8. PubMed ID: 24627266
    [Abstract] [Full Text] [Related]

  • 67. The epidemiology of recurrent Gram-negative bacteremia in a tertiary-care hospital.
    Marschall J, Doherty J, Warren DK.
    Diagn Microbiol Infect Dis; 2010 Apr 15; 66(4):456-9. PubMed ID: 20226339
    [Abstract] [Full Text] [Related]

  • 68. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
    Shi SH, Kong HS, Xu J, Zhang WJ, Jia CK, Wang WL, Shen Y, Zhang M, Zheng SS.
    Transpl Infect Dis; 2009 Oct 15; 11(5):405-12. PubMed ID: 19638006
    [Abstract] [Full Text] [Related]

  • 69. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.
    Abbott IJ, Slavin MA, Turnidge JD, Thursky KA, Worth LJ.
    Expert Rev Anti Infect Ther; 2011 Apr 15; 9(4):471-88. PubMed ID: 21504403
    [Abstract] [Full Text] [Related]

  • 70. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.
    Pinholt M, Ostergaard C, Arpi M, Bruun NE, Schønheyder HC, Gradel KO, Søgaard M, Knudsen JD, Danish Collaborative Bacteraemia Network (DACOBAN).
    Clin Microbiol Infect; 2014 Feb 15; 20(2):145-51. PubMed ID: 23647880
    [Abstract] [Full Text] [Related]

  • 71. Siderophores of Stenotrophomonas maltophilia: detection and determination of their chemical nature.
    García CA, Passerini De Rossi B, Alcaraz E, Vay C, Franco M.
    Rev Argent Microbiol; 2012 Feb 15; 44(3):150-4. PubMed ID: 23102461
    [Abstract] [Full Text] [Related]

  • 72. Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa.
    Vidal F, Mensa J, Almela M, Olona M, Martínez JA, Marco F, López MJ, Soriano A, Horcajada JP, Gatell JM, Richart C.
    QJM; 2003 Mar 15; 96(3):227-34. PubMed ID: 12615987
    [Abstract] [Full Text] [Related]

  • 73. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron.
    Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, Li X, Li JB.
    Int J Antimicrob Agents; 2011 Mar 15; 37(3):230-4. PubMed ID: 21296557
    [Abstract] [Full Text] [Related]

  • 74. Stenotrophomonas maltophilia bacteremia in burn patients.
    Tsai WP, Chen CL, Ko WC, Pan SC.
    Burns; 2006 Mar 15; 32(2):155-8. PubMed ID: 16448762
    [Abstract] [Full Text] [Related]

  • 75. Unique characteristics of community-onset healthcare- associated bloodstream infections: a multi-centre prospective surveillance study of bloodstream infections in Japan.
    Takeshita N, Kawamura I, Kurai H, Araoka H, Yoneyama A, Fujita T, Ainoda Y, Hase R, Hosokawa N, Shimanuki H, Sekiya N, Ohmagari N.
    J Hosp Infect; 2017 May 15; 96(1):29-34. PubMed ID: 28377180
    [Abstract] [Full Text] [Related]

  • 76. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
    Gallo SW, Figueiredo TP, Bessa MC, Pagnussatti VE, Ferreira CA, Oliveira SD.
    Microb Drug Resist; 2016 Dec 15; 22(8):688-695. PubMed ID: 27007167
    [Abstract] [Full Text] [Related]

  • 77. Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases.
    Metan G, Demiraslan H, Kaynar LG, Zararsız G, Alp E, Eser B.
    Braz J Infect Dis; 2013 Dec 15; 17(2):143-9. PubMed ID: 23485438
    [Abstract] [Full Text] [Related]

  • 78. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
    Kim EJ, Kim YC, Ahn JY, Jeong SJ, Ku NS, Choi JY, Yeom JS, Song YG.
    BMC Infect Dis; 2019 Aug 28; 19(1):754. PubMed ID: 31462215
    [Abstract] [Full Text] [Related]

  • 79. Stenotrophomonas maltophilia bacteraemia in Turkish children.
    Güriz H, Ciftçi E, Ayberkin E, Aysev D, Ince E, Arsan S, Yavuz G, Doğru U.
    Ann Trop Paediatr; 2008 Jun 28; 28(2):129-36. PubMed ID: 18510823
    [Abstract] [Full Text] [Related]

  • 80. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study.
    Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB.
    Infect Control Hosp Epidemiol; 2003 Apr 28; 24(4):269-74. PubMed ID: 12725356
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.